What is BioIQ?
Headquartered in Atlanta, Georgia, BioIQ is a health technology company that has fundamentally transformed the landscape of health measurement and diagnostic testing. By developing a sophisticated software infrastructure, the company facilitates seamless connections between individuals and health service providers, thereby increasing the accessibility of critical health screenings. This platform not only empowers users with actionable health insights but also provides healthcare partners with increased touch points, fostering a more integrated and efficient approach to population health management. BioIQ's market position is defined by its commitment to simplifying complex health data, making it a vital partner for organizations seeking to improve patient outcomes and reduce overall healthcare costs.
How much funding has BioIQ raised?
BioIQ has raised a total of $46.5M across 6 funding rounds:
Other Financing Round
$436K
Other Financing Round
$492K
Private Equity
$10M
Private Equity
$7.1M
Unspecified
$26.5M
Debt
$2M
Other Financing Round (2009): $436K with participation from Persistence Partners
Other Financing Round (2010): $492K led by Persistence Partners
Private Equity (2015): $10M, investors not publicly disclosed
Private Equity (2016): $7.1M, investors not publicly disclosed
Unspecified (2018): $26.5M backed by HealthQuest Capital and Arboretum Ventures
Debt (2020): $2M with participation from PPP
Key Investors in BioIQ
Arboretum Ventures
Arboretum Ventures is a Midwest-based healthcare venture capital firm with over 20 years of experience in investing in innovative healthcare solutions. The firm focuses on early-stage startups in under-ventured markets, aiming to improve patient outcomes and reduce healthcare costs through strategic partnerships and investments.
Persistence Partners
Persistence Partners is an early-stage venture fund based in Santa Barbara and Ventura Counties that focuses on funding entrepreneurial teams capable of leveraging technology to solve problems and grow businesses.
HealthQuest Capital
HealthQuest Capital is a specialized investment firm focused on growth-stage healthcare companies that are improving patient outcomes and reducing costs through innovative technology and services.
What's next for BioIQ?
With the successful acquisition of $2M, BioIQ is well-positioned to scale its enterprise health solutions and deepen its market penetration. The company's strategic roadmap likely involves enhancing its software capabilities to support more complex diagnostic workflows and expanding its network of health service partners. As the demand for decentralized and accessible health testing continues to rise, BioIQ's focus on creating a frictionless user experience will be critical in maintaining its competitive edge. The firm is expected to leverage this capital to drive further innovation in its digital health platform, ensuring that it remains at the forefront of the industry's shift toward proactive, data-driven health management.
See full BioIQ company page
